ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 183 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 6.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,546,000 | 0.0% | 191,575 | +17.2% | 0.00% | 0.0% |
| Q4 2018 | $2,546,000 | -9.7% | 163,432 | +13.9% | 0.00% | 0.0% |
| Q3 2018 | $2,820,000 | +20.5% | 143,523 | +62.1% | 0.00% | 0.0% |
| Q1 2016 | $2,341,000 | -67.6% | 88,523 | -47.6% | 0.00% | -62.5% |
| Q4 2015 | $7,225,000 | +27.4% | 168,892 | -21.0% | 0.01% | +14.3% |
| Q3 2015 | $5,669,000 | +2.5% | 213,848 | +28.8% | 0.01% | +16.7% |
| Q2 2015 | $5,533,000 | +7.8% | 166,008 | +7.6% | 0.01% | 0.0% |
| Q1 2015 | $5,132,000 | -22.0% | 154,212 | -4.2% | 0.01% | -14.3% |
| Q4 2014 | $6,581,000 | +475.3% | 161,022 | +376.9% | 0.01% | +600.0% |
| Q3 2014 | $1,144,000 | +5.2% | 33,764 | +4.7% | 0.00% | 0.0% |
| Q2 2014 | $1,087,000 | -14.1% | 32,235 | -3.4% | 0.00% | 0.0% |
| Q1 2014 | $1,265,000 | +26.5% | 33,364 | -2.6% | 0.00% | 0.0% |
| Q4 2013 | $1,000,000 | -30.5% | 34,244 | -18.4% | 0.00% | -50.0% |
| Q3 2013 | $1,438,000 | +9.3% | 41,962 | +5.2% | 0.00% | 0.0% |
| Q2 2013 | $1,316,000 | – | 39,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |